1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Mexico
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in The United States
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Company Profiles
9.1. BASF SE
9.2. Sinopharm Group Co Ltd
9.3. F. Hoffmann-La Roche Ltd
9.4. The Procter & Gamble Co
9.5. Shanghai Pharmaceuticals Holding Co Ltd
9.6. CSPC Pharmaceutical Group Ltd
9.7. Takeda Pharmaceutical Co Ltd
9.8. Novartis AG
9.9. GSK plc
9.10. AstraZeneca Plc
9.11. Sanofi
9.12. Roche Holding AG
9.13. Laboratoires Pierre Fabre SA
9.14. Ipsen SA
9.15. Les Laboratoires Servier SAS
9.16. Bayer AG
9.17. Boehringer Ingelheim GmbH
9.18. CSL Ltd
9.19. Astrazeneca Pty Ltd
9.20. Mayne Pharma Group Ltd
9.21. Hypera SA
9.22. Ache Laboratorios Farmaceuticos SA
9.23. EMS Sigma Pharma
9.24. Eurofarma Laboratorios SA
9.25. Johnson & Johnson
9.26. Sanofi-Aventis Canada Inc
9.27. Apotex Inc
9.28. Bausch Health Companies Inc
9.29. Jiangsu Hengrui Medicine Co Ltd
9.30. Lupin Ltd
9.31. Cipla Ltd
9.32. Dr. Reddy's Laboratories Ltd
9.33. PT Kalbe Farma Tbk
9.34. PT Kimia Farma Tbk
9.35. PT Tempo Scan Pacific Tbk
9.36. Pfizer Italia Srl
9.37. A. Menarini Industrie Farmaceutiche Riunite Srl
9.38. Chiesi Farmaceutici SpA
9.39. Recordati SpA
9.40. Daiichi Sankyo Co Ltd
9.41. Astellas Pharma Inc
9.42. Otsuka Holdings Co Ltd
9.43. Sanofi-Aventis de Mexico SA de CV
9.44. Genomma Lab Internacional SAB de CV
9.45. Bayer de Mexico SA de CV
9.46. Boehringer Ingelheim Mexico
9.47. Pfizer BV
9.48. Astellas Pharma Europe Ltd
9.49. Merck & Co Inc
9.50. AbbVie Inc
9.51. Pfizer Inc
9.52. Bristol-Myers Squibb Co
9.53. OTC Pharma International BV
9.54. Pharmstandard
9.55. Binnopharm Group
9.56. Novo Nordisk AS
9.57. H. Lundbeck AS
9.58. Pfizer Laboratories (Pty) Ltd
9.59. Aspen Pharmacare Holdings Ltd
9.60. Adcock Ingram Holdings Ltd
9.61. Chong Kun Dang Pharmaceutical Corp.
9.62. Yuhan Corp
9.63. Celltrion Inc
9.64. Hanmi Pharmaceuticals Co Ltd
9.65. Grifols SA
9.66. Almirall SA
9.67. Laboratorios Farmaceuticos Rovi SA
9.68. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
9.69. Deva Holding AS
10 Appendix
10.1. Methodology
10.2. About the Publisher
List of Tables
Table 1: NAFTA countries pharmaceuticals industry, revenue ($bn), 2019-28
Table 2: NAFTA countries pharmaceuticals industry, revenue ($bn), 2019-23
Table 3: NAFTA countries pharmaceuticals industry forecast, revenue ($bn), 2023-28
Table 4: Canada pharmaceuticals market value: $ billion, 2018-23
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2023
Table 6: Canada pharmaceuticals market value forecast: $ billion, 2023-28
Table 7: Canada Size of Population (million), 2019-23
Table 8: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 9: Canada GDP (Current Prices, $ Billion), 2019-23
Table 10: Canada Inflation, 2019-23
Table 11: Canada Consumer Price Index (Absolute), 2019-23
Table 12: Canada exchange rate, 2018-23
Table 13: Mexico pharmaceuticals market value: $ billion, 2018-23
Table 14: Mexico pharmaceuticals market geography segmentation: $ billion, 2023
Table 15: Mexico pharmaceuticals market value forecast: $ billion, 2023-28
Table 16: Mexico Size of Population (million), 2019-23
Table 17: Mexico real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 18: Mexico GDP (Current Prices, $ Billion), 2019-23
Table 19: Mexico Inflation, 2019-23
Table 20: Mexico Consumer Price Index (Absolute), 2019-23
Table 21: Mexico exchange rate, 2018-23
Table 22: United States pharmaceuticals market value: $ billion, 2018-23
Table 23: United States pharmaceuticals market geography segmentation: $ billion, 2023
Table 24: United States pharmaceuticals market value forecast: $ billion, 2023-28
Table 25: United States Size of Population (million), 2019-23
Table 26: United States real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 27: United States GDP (Current Prices, $ Billion), 2019-23
Table 28: United States Inflation, 2019-23
Table 29: United States Consumer Price Index (Absolute), 2019-23
Table 30: United States exchange rate, 2018-23
Table 31: BASF SE: key facts
Table 32: BASF SE: Annual Financial Ratios
Table 33: BASF SE: Key Employees
Table 34: Sinopharm Group Co Ltd: key facts
Table 35: Sinopharm Group Co Ltd: Annual Financial Ratios
Table 36: Sinopharm Group Co Ltd: Key Employees
Table 37: F. Hoffmann-La Roche Ltd: key facts
Table 38: F. Hoffmann-La Roche Ltd: Key Employees
Table 39: The Procter & Gamble Co: key facts
Table 40: The Procter & Gamble Co: Annual Financial Ratios
Table 41: The Procter & Gamble Co: Key Employees
Table 42: The Procter & Gamble Co: Key Employees Continued
Table 43: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 44: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 45: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 46: CSPC Pharmaceutical Group Ltd: key facts
Table 47: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 48: CSPC Pharmaceutical Group Ltd: Key Employees
Table 49: Takeda Pharmaceutical Co Ltd: key facts
Table 50: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 51: Takeda Pharmaceutical Co Ltd: Key Employees
Table 52: Takeda Pharmaceutical Co Ltd: Key Employees Continued
Table 53: Novartis AG: key facts
Table 54: Novartis AG: Annual Financial Ratios
Table 55: Novartis AG: Key Employees
Table 56: GSK plc: key facts
Table 57: GSK plc: Annual Financial Ratios
Table 58: GSK plc: Key Employees
Table 59: AstraZeneca Plc: key facts
Table 60: AstraZeneca Plc: Annual Financial Ratios
Table 61: AstraZeneca Plc: Key Employees
Table 62: Sanofi: key facts
Table 63: Sanofi: Annual Financial Ratios
Table 64: Sanofi: Key Employees
Table 65: Sanofi: Key Employees Continued
Table 66: Roche Holding AG: key facts
Table 67: Roche Holding AG: Annual Financial Ratios
Table 68: Roche Holding AG: Key Employees
Table 69: Laboratoires Pierre Fabre SA: key facts
Table 70: Laboratoires Pierre Fabre SA: Key Employees
Table 71: Ipsen SA: key facts
Table 72: Ipsen SA: Annual Financial Ratios
Table 73: Ipsen SA: Key Employees
Table 74: Ipsen SA: Key Employees Continued
Table 75: Les Laboratoires Servier SAS: key facts
Table 76: Les Laboratoires Servier SAS: Key Employees
Table 77: Bayer AG: key facts
Table 78: Bayer AG: Annual Financial Ratios
Table 79: Bayer AG: Key Employees
Table 80: Bayer AG: Key Employees Continued
Table 81: Boehringer Ingelheim GmbH: key facts
Table 82: Boehringer Ingelheim GmbH: Key Employees
Table 83: CSL Ltd: key facts
Table 84: CSL Ltd: Annual Financial Ratios
Table 85: CSL Ltd: Key Employees
Table 86: Astrazeneca Pty Ltd: key facts
Table 87: Astrazeneca Pty Ltd: Key Employees
Table 88: Mayne Pharma Group Ltd: key facts
Table 89: Mayne Pharma Group Ltd: Annual Financial Ratios
Table 90: Mayne Pharma Group Ltd: Key Employees
Table 91: Hypera SA: key facts
Table 92: Hypera SA: Annual Financial Ratios
Table 93: Hypera SA: Key Employees
List of Figures
Figure 1: NAFTA countries pharmaceuticals industry, revenue ($bn), 2019-28
Figure 2: NAFTA countries pharmaceuticals industry, revenue ($bn), 2019-23
Figure 3: NAFTA countries pharmaceuticals industry forecast, revenue ($bn), 2023-28
Figure 4: Canada pharmaceuticals market value: $ billion, 2018-23
Figure 5: Canada pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 6: Canada pharmaceuticals market value forecast: $ billion, 2023-28
Figure 7: Forces driving competition in the pharmaceuticals market in Canada, 2023
Figure 8: Drivers of buyer power in the pharmaceuticals market in Canada, 2023
Figure 9: Drivers of supplier power in the pharmaceuticals market in Canada, 2023
Figure 10: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2023
Figure 11: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2023
Figure 12: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2023
Figure 13: Mexico pharmaceuticals market value: $ billion, 2018-23
Figure 14: Mexico pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 15: Mexico pharmaceuticals market value forecast: $ billion, 2023-28
Figure 16: Forces driving competition in the pharmaceuticals market in Mexico, 2023
Figure 17: Drivers of buyer power in the pharmaceuticals market in Mexico, 2023
Figure 18: Drivers of supplier power in the pharmaceuticals market in Mexico, 2023
Figure 19: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2023
Figure 20: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2023
Figure 21: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2023
Figure 22: United States pharmaceuticals market value: $ billion, 2018-23
Figure 23: United States pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 24: United States pharmaceuticals market value forecast: $ billion, 2023-28
Figure 25: Forces driving competition in the pharmaceuticals market in the United States, 2023
Figure 26: Drivers of buyer power in the pharmaceuticals market in the United States, 2023
Figure 27: Drivers of supplier power in the pharmaceuticals market in the United States, 2023
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2023
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2023
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2023
